Hyderabad, India -- (SBWire) -- 02/23/2018 --Atopic dermatitis is the most well-known kind of skin inflammation. Actually, more than 18 million American grown-ups have atopic dermatitis — which regularly shows up as a red, irritated rash typically on the cheeks, arms, and legs. Atopic dermatitis normally starts in adolescence, for the most part in the initial half year of an infant's life. Despite the fact that it's a typical type of skin inflammation, it's additionally serious and durable. The causes of this medical condition are still unknown but are suspected to be hereditary.
View Sample Report: https://www.marketdataforecast.com/market-reports/atopic-dermatitis-treatment-market-5354/request-sample
The global Atopic dermatitis treatment market value is evaluated to be USD 7.23 Billion in 2017 and is estimated to reach USD 13.32 Billion by 2022 at a CAGR of 13%.
Read the full report: https://www.marketdataforecast.com/market-reports/atopic-dermatitis-treatment-market-5354/
Growing cases of food allergies will boost the market growth in the forecast period. As indicated by a survey, right around 33% of the youngsters with atopic dermatitis are determined to have food hypersensitivity. For example, it is estimated that 5%-10% of all kids have atopic dermatitis, and 33% of them have food allergies. One of the central points in charge of the developing danger of extreme atopic dermatitis in early stages is identified with food sensitization, which is generally connected with food hypersensitivity. Food allergies predominantly result from the bovine's drain, chicken eggs, peanuts, wheat, soy, nuts, and fish.
The quantity of patients experiencing atopic dermatitis has fundamentally expanded amid the most recent three decades. As indicated by the National Eczema Association (NEA), AD influences about 10% to 20% of infants in the U.S. In Asia-Pacific, India and China are the significant nations representing a bigger extent of the cases.
Customize report: https://www.marketdataforecast.com/market-reports/atopic-dermatitis-treatment-market-5354/customize-report
Geographically, North America is dominating the market and is expected to do so in the upcoming years owing to the high investment in health care and high awareness towards available treatments. Europe occupies the second biggest market share globally and Asia-pacific is expected to witness a major growth rate during the forecast period.
Some of the key players of Atopic dermatitis market include Astellas Pharma Inc., Valeant Pharmaceuticals International, Inc., and Sanofi S.A. Other players in the market include Anacor Pharmaceuticals, Inc. Meda Pharmaceuticals, Regeneron Pharmaceuticals Inc., and Novartis International AG, Pfizer Inc.
About MarketDataForecast™
Market Data Forecast is a market research firm offering syndicated research, consults and industry newsletters across various domains & verticals. With a well-established in-house team of experts from diverse fields and outsource research network across 100+ countries, we are the sole research providers for the majority of Fortune 500 companies. Along with the standards of reports being on par excellence, our unique services like free customization, analyst support for the period of six months post to the purchase will be the flag bearers and differentiates us from the rest. Our experience and in-depth understanding of various business environments will be a support to you and your organization in making well-informed decisions.
Related reports:
Colorectal Cancer Market - https://www.marketdataforecast.com/market-reports/global-colorectal-cancer-market-612/
Clinical Nutrition Market- https://www.marketdataforecast.com/market-reports/global-clinical-nutrition-market-785/
Contact Info:
Name: Mr. Abhishek Shukla
Email: abhishek@marketdataforecast.com
Organization: MarketDataForecast™
Address: 2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
Phone: +1-888-702-9626
